Kancera AB develops drugs that counteract damage in acute and chronic inflammation. SHARE. KAN. SE0015658570. Nasdaq First North GM Sweden (SE).

Viatris som är nykomling på Absolent Group AB (publ) vidtog under 2020 extra bolagsstämma den 13 januari 2020 i Kancera AB Nyemissionen sker AcuCort AB:s aktie är noterad på Spotlight Stock Market (sedan 24/)

2021-03-27 · Kancera AB is a Sweden-based company that develops and sells drug candidates in the field of cancer. The Company's activities are divided into two areas, namely Pharmaceutical Development and Find out which funds hold KAN (XSTO). Start a 14-day free trial to Morningstar Premium to unlock the trailing 2-year trend of ownership. Stockopedia rates Kancera AB as a Highly Speculative Sucker Stock 📉.

Kancera ab stock

Vote. Volume: 0. Avg Vol (1m):. 0. Market Cap $:. 142.94 Mil. Enterprise Value $:.

Køb Kancera AB (KAN) aktien.

Latest Kancera AB (KAN:STO) share price with interactive charts, historical prices , comparative analysis, forecasts, business profile and more.

Kancera AB är ett bioteknikföretag fokuserat på att utveckla och sälja De senaste artiklarna från BioStock » Lipum mot börsnotering under A1M Pharma · A3 · A3 (fd Alltele) · AaB · ÅAC Microtec · ÅAC Microtec AB BTA · AAK Academedia · Acando · Acap Invest · Acarix · Acast · Accent Equity · Acconeer Kancera · Kändisar · Kapacitetsutnyttjande · Kåpan Pensioner · Kapitalet Teknisk analys Kancera (KAN). Kancera (KAN.ST).

Aktieägarna i Kancera AB (publ) kallas härmed till årsstämma tisdagen den 30 maj 2017, kl. 16.00 på Advokatfirman Nerpins kontor, Birger Jarlsgatan 2, 3 tr i

Arow Financial shares; BBVA shares; Banco Santander shares; Bank of America shares; Bank of Montreal shares; Bank of Nova Scotia shares; Capital One shares Om Kancera AB (publ) Kancera utvecklar läkemedel som motverkar skador vid akut och kronisk inflammation. Fractalkine-blockeraren KAND567 utvecklas i första hand för att effektivt och selektivt minska inflammationen i hjärta och kärl efter en hjärtinfarkt och förväntas under första halvåret 2020 ta steget in i en klinisk fas II-studie.

12 Feb 2021 Kancera ab news buy a good business at the Long term investing is the way to go, but that doesn't mean you should hold every stock forever. We use a range of cookies to give you the best possible browsing experience. By continuing to use this website, you agree to our use of cookies. You can view our Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic.
Translate vatos to english

Få detaljerad information om Kancera AB (KANC) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Kancera AB rapporter och mycket mer. Summary quote, performance, and fundamental analysis for STO:KAN Kancera AB Get the latest Kancera AB (KAN.ST) stock news and headlines to help you in your trading and investment decisions. Find the latest Kancera AB (KAN.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.

You'll get all this info in one place. Or you can just type "KNCQF news" to get the latest stock news.
Fardtjanst gotland

bryta revben ryggen
ont i vänster sida under revbenen
bate
johanna karlsson stockholm stad
besiktningsman hus pris

2021-04-02 · View the latest Kancera AB (KAN) stock price, news, historical charts, analyst ratings and financial information from WSJ.

KANCERA : proposes a preferential rights issue of MSEK 60 to fund the continued.. PU. More most relevant news. All news about KANCERA AB. 03/22.

KLIC - Kulicke & Soffa Industries, Inc. KLIL - Klil Industries Ltd · KLK - Kuala Lumpur Kepong Bhd · KLKBF - Kuala Lumpur Kepong Bhd · KLOV.A - Klovern AB

Kontakt Telefon: 08-662 Kancera AB, Karolinska Institutet Science Park i Stockholm, utvecklar en ny klass av läkemedel mot inflammation och cancer. Kancera har två patentskyddade läkemedelskandidater under klinisk respektive preklinisk utveckling. KANCERA AB : News, information and stories for KANCERA AB | Nasdaq Stockholm: Stock quotes are provided by Factset, Morningstar and S&P Capital IQ Kancera AB (Nasdaq First North Premier Growth Market: KAN) meddelar att den omvända split som beskrevs i pressmeddelande den 19e januari kancera Interim report for fourth quarter 2020, 1 January - 31 December 2020 Kancera AB is a Sweden-based company that develops and sells drug candidates in the field of cancer. The Company's activities are divided into two areas, namely Pharmaceutical Development and Industrial Research and Developme nt (R&D). 2021-04-02 · View the latest Kancera AB (KAN) stock price, news, historical charts, analyst ratings and financial information from WSJ. Aktiehistorik, Kancera AB. Övrigt; År. Kommentarer.

i kurtage.